2023 European Liver Association: Aligos' Five Innovative hepatitis B Drugs Development Core Content and Prospects

AligosTherapeutics in the clinical phase brought a total of five new research advances in innovative hepatitis B drugs at the 2023 European Liver Annual Conference (EASL2023), including two candidate drugs in the phase I clinical development phase, and progress in compounds in the pre clinical research phase. The following are the core contents of these 5 research developments and comments during the Aligos European Liver Conference...

Tech >>